The Xenopus laevis a-tropomyosin (TM) gene, like its vertebrates counterparts, encodes muscle and non-muscle isoforms through two promoters and alternatively spliced exons. In the present study we describe a cDNA clone (XTMa 7) encoding a skeletal muscle isoform of the gene that differs from the previously described skeletal TM transcript (XTMa 2) by its 3 H UTR sequence. The two skeletal a-TM encoding mRNAs are generated through distinct 3 H end processing using different polyA signals and distinct patterns of exon splicing. Using RNAse protection and RNA in situ hybridization, we have analysed the developmental and spatial expression of the two transcripts. Both are expressed in the embryo, but XTMa 7 is by far the most prevalent of the two. In contrast, only XTMa 2 is expressed in adult striated muscle tissues. In the embryo, the spatial expression of XTMa 7 is restricted to the somites whereas XTMa 2 is expressed in both somites and embryonic heart. q
Results
Tropomyosins (TMs) are actin-binding proteins, with distinct muscle and non-muscle isoforms, that are found in all eukaryotic cells (Lees-Miller and Helfman, 1991) . In striated muscle, TMs are components of the thin ®lament where, in association with the troponin complex, they regulate contraction (Smillie, 1979) . In non-muscle cells they are involved in various micro®lament-associated processes (Pittenger et al., 1994) . We have characterized three functional TM genes in Xenopus laevis, the a-TM, b-TM and TM-4 genes, that are expressed in a complex temporal and tissue-speci®c pattern (Hardy et al., 1991 (Hardy et al., , 1995 Hardy and Thie Âbaud, 1992; Gaillard et al., 1998a Gaillard et al., ,b, 1999 . We report here a new Xenopus laevis skeletal a-TM encoding cDNA (XTMa 7) that differs from the skeletal muscle a -TM transcript previously described (XTMa 2) only by its 3 H UTR. Sequence analysis indicated that XTMa 7 was identical to the skeletal a -TM clone XTMa 2 except that the carboxyterminal residue is Met rather than Ile. In addition, their
3
H UTR sequences are totally divergent (Fig. 1A) . Comparison of cDNA sequences XTMa7 and XTMa 2 with the genomic sequence that covers exons 9a to 9b indicates that the two mRNAs are subject to a different 3 H end processing (data not shown). XTMa 2 mRNA is generated by the splicing of the COOH terminal coding region (exon 9a, amino acids 258 to 284) to exon 9b, that provides an in frame stop codon and the 3 H UTR sequence (Fig. 1B) . In the pre-mRNA maturation process that leads to XTMa 7 mRNA, there is no splicing of exon 9a to exon 9b, and the 3 H UTR region of the matured transcript corresponds to a part of the intronic region that separates the two exons (Fig. 1B) .
The expression of XTMa 7 and XTMa 2 transcripts was analysed by RNase protection assay with the respective probes XTMa74 and XTMa27 that can discriminate between the two transcripts and allow an estimate of their relative proportion in any RNA population. The full protected fragments obtained with XTMa 74 (290 nt) and XTMa 27 (339 nt) probes identify XTMa 7 and XTMa 2 transcripts, respectively. Each probe can also protect a 214 nt fragment that corresponds to the common sequences between the two mRNAs over exons 7±8±9a (Fig. 1B) . As (2) was analysed by RNase protection with XTMa27 or XTMa74 probes. M, size markers (HpaII-digested pBluescript); muscle RNAs were from longissimus dorsi (Ld), gastrocnemius (Gc) or heart (H). Synthetic sense RNA derived from XTMa2 (a2) and XTMa7 (a7) cDNAs were used as control. The discrepancy between the size of the probes (P) and the 339 nt protected fragment for XTMa27 or the 290 nt fragment for XTMa74 probe corresponds to the polylinker sequence included in the antisense probes.
shown in Fig. 1C, XTMa7 and XTMa 2 transcripts are expressed in stage 42 embryo (Fig. 1C, lanes 3 and 11) . The 260 nt intermediate protected fragment observed with XTMa74 probe (Fig. 1C, lane 11) corresponds to a 3 nt discrepancy between the duplicated a -TM genes sequences (data not shown). The relative signal intensity between the protected fragments indicates that XTMa 7 transcripts are more prevalent than XTMa2 transcripts and represent up to 90% of the total skeletal muscle a-TM transcripts content at this developmental stage. Analysis of RNA from adult striated muscles showed that XTMa 2 transcripts are highly expressed in skeletal and heart tissues whereas XTMa 7 transcripts are not expressed at all in those tissues (Fig.  1C, compare lanes 4±6 to lanes 12±14) . During development, the two transcripts are ®rst detected in stage 15 embryo and they seem to accumulate synchronously with a roughly similar quantitative ratio (Fig. 2A) . The spatial expression of the two transcripts in the embryo was analysed by whole-mount in situ hybridization with 3 H UTR speci®c probes. As shown in Fig. 2B , the two transcripts are detected in the somites of tailbud embryos and the only marked difference between them is that XTMa7 transcripts are not expressed in embryonic heart. The newly described skeletal a -TM transcript is therefore subject to a strict temporal and spatial controlled expression with respect to the skeletal and cardiac lineages.
Materials and methods

Isolation and characterization of cDNA clones
A Xenopus laevis stage 42 embryo cDNA library was screened under high stringency conditions using the complete XTMa2 cDNA as a probe (Hardy et al., 1991) . The inserts were subcloned into a pBluescript vector (Stratagene) and sequenced.
RNA analysis
RNase protection analysis was carried out as described before (Gaillard et al., 1998a) . XTMa 27 and XTMa 74 probes have been subcloned from the complete plasmid XTMa 2 and XTMa7 by standard methods (Sambrook et al., 1989) . The 3 H UTR speci®c probe for XTMa 2 is described in Hardy et al. (1991) . The probe XTMa 73 corresponding to the 3 H UTR of XTMa 7 was PCR engineered and subcloned into pBluescript vector (Stratagene).
In situ hybridization
Whole-mount RNA in situ hybridization was performed as described by Harland (1991) , using a digoxygeninlabelled probe. 
